Extracellular vesicle-based oral vaccine for the prevention of giardiasis, namely Diarrheal Disease, an infection caused by the protozoa Giardia lamblia (also known as Giardia intestinalis or Giardia duodenalis).

Problem to tackle:
- ~1.7 billion cases of diarrheal disease are reported globally each year
- Diarrheal disease is the 2º leading cause of death worldwide
- Loss of worker productivity and direct impact on healthcare systems